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Identification of Novel Genes and Pathways Affecting Salmonella Type
III Secretion System 1 Using a Contact-Dependent Hemolysis Assay
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We screened 5,700 Salmonella enterica serovar Typhimurium mutants for defects in type III secretion system
1 (T3SS-1)-mediated contact-dependent hemolysis to identify novel genes and pathways affecting the activity of
T3SS-1. Our data suggest that previously unrecognized factors such as type I fimbriae may modulate the
expression, activity, or deployment of this key virulence factor.
Type III secretion systems (T3SSs) are found in many gram-
negative bacteria and are used to secrete and translocate a
range of bacterial proteins known as effectors directly into the
host cell (reviewed in reference 6). Salmonella possesses two
T3SSs which are used at distinct stages of the infection process.
T3SS-1, encoded within Salmonella pathogenicity island 1
(SPI-1), is required for the initial invasion of host cells and the
induction of enteropathogenic responses (reviewed in 14, 22),
while T3SS-2, encoded within SPI-2, is used in the later stages
of infection, promoting survival and replication of Salmonella
within host cells (reviewed in reference 1).
Lysis of erythrocytes in a manner dependent upon T3SSs has
been observed in a number of bacteria including Shigella, en-
teropathogenic Escherichia coli, Yersinia, Bordetella and Salmo-
nella (8, 10, 12, 15, 23). In Salmonella, hemolysis is dependent
upon the ability of the T3SS-1 translocator proteins SipB,
SipC, and SipD to form a pore in the erythrocyte membrane,
causing hemoglobin leakage (15). In vitro, contact-dependent
hemolysis can be monitored by incubating Salmonella strains
with sheep red blood cells (SRBC) and measuring the absor-
bance of the culture supernatant to detect the presence of re-
leased hemoglobin (15). In this work we used a high-throughput
contact-dependent hemolysis assay to screen a Salmonella enterica
serovar Typhimurium mutant bank with the aim of identifying
novel genes or pathways involved in regulation of Salmonella
T3SS-1.
Screening serovar Typhimurium mutants for contact-de-
pendent hemolysis. An S. enterica serovar Typhimurium 4/74
nalidixic acid-resistant (Nalr) signature-tagged transposon in-
sertion mutant (STM) bank of 5,700 independent mutants (17)
was screened. Bacterial strains in 96-well plates grown overnight
in Luria Bertani (LB) medium at 21°C were subcultured and
incubated at 37°C for 90 min to induce expression of T3SS-1.
Bacteria were recovered by centrifugation, resuspended in fresh
LB medium, and assessed for their ability to lyse SRBC essentially
as described previously (15). Briefly, defibrinated sheep blood
(TCS Biosciences Ltd., Buckingham, United Kingdom) was cen-
trifuged at 5,700  g for 5 min at 4°C to pellet RBC. The RBC
were washed four times in phosphate-buffered saline (PBS) and
then resuspended in an equal volume of PBS to give a 50%
(vol/vol) SRBC-PBS suspension. Fifty microliters of bacterial cul-
ture was mixed with 50 l of SRBC-PBS suspension in a 96-well
plate and centrifuged at 1,279  g for 10 min to aid contact
between bacteria and SRBC. Following a 4-h incubation at 37°C,
cells were resuspended by the addition of 150 l of PBS and
centrifuged at 1,279  g for 10 min. A total of 100 l of super-
natant from each well was transferred to a flat-bottomed 96-well
plate, and the absorbance was recorded at 550 nm to detect the
presence of released hemoglobin.
From this initial screen of 5,700 serovar Typhimurium 4/74
mutants, 447 showed decreased hemolytic activity (approxi-
mately 60% or less activity compared to the plate average), of
which 174 were classed as negative since they were unable to
induce lysis of SRBC. The value of 60% was chosen following
assessment of variance in the assay. Following the initial
screen, any mutants showing reduced hemolysis were screened
three more times in the hemolysis assay to confirm the phe-
notype. To allow for variation between biological replicates in
the additional screens, each plate contained a positive (serovar
Typhimurium 4/74 wild type) and negative control. Absor-
bance values were adjusted to remove background hemolysis
using a negative control of RBC without bacteria. Results were
then expressed as hemolytic activity as a percentage of wild-
type bacteria (positive control), where the wild type was
classed as inducing 100% hemolysis. Mutants with hemolytic
activity of less than 60% were classed as showing decreased
hemolysis compared to wild-type bacteria, and mutants with a
value of 10% or less were classed as negative (unable to induce
hemolysis). The optical density at 550 nm (OD550) of the
bacterial cultures was measured prior to incubation with the
SRBC in the hemolysis assay, and some mutants with reduced
growth (40 to 60% of wild-type) were retested in the hemolysis
assay with bacterial numbers adjusted so that they were similar
to the wild-type strain. Mutants with substantially impaired
growth rates were rejected for further analysis. Pilot studies
indicated that the extent of hemolysis was growth phase de-
pendent, with bacteria in early or mid-logarithmic phase being
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less hemolytic than those in late exponential phase. Though
hemolytic activity was sensitive to growth phase, it was not
affected by the starting bacterial density as diluting cultures
through 80, 60, 40, and 20% of the starting OD550 did not
impair hemolytic activity. Thus, if equivalent numbers of bac-
teria enter the assay and if mutants with impaired growth are
rejected, one may anticipate that mutants with altered hemo-
lytic activity carry mutations that directly affect the expression,
function, or deployment of T3SS-1.
Identification of mutants with reduced T3SS-1-mediated he-
molytic activity. For the remainder of this study we focused on
mutants that we had classified as reduced or negative in the
hemolysis screen.
Since a large number of mutants exhibiting impaired hemolytic
activity were predicted to have defects in SPI-1, the chromosomal
DNA region encoding T3SS-1, a PCR screen was performed to
identify and eliminate such mutants. Four primers spanning the
T3SS-1 apparatus-encoding region of SPI-1 (T3SS-P01, 5-TGC
CTGCTATTCAGGAAACA-3; T3SS-P02, 5-CAGGATGGG
AGGCTATTCAA-3; T3SS-P03, 5-CACCCATGATGGCGTA
TAGA-3; and T3SS-P04, 5-TTTTCGCCAGGACGATATTC-
3) were used in PCRs with the transposon-specific primers P6
(5-CCTAGGCGGCCAGATCTG-3) and P10 (5-TCCTCTA
GAGTCGACCTG-3). Genomic DNA from each mutant was
prepared according to standard procedures and used as a tem-
plate in the PCRs. Any mutant that generated a product was
discarded as the transposon insertion would be in an SPI-1 gene.
This method eliminated approximately 50% of the mutants. The
remaining mutants were then identified by subcloning and se-
quencing to map transposon insertion sites as previously de-
scribed (17) with the exception that sequencing was carried out
in-house using Beckman CEQ8000 sequencers.
Twenty-three genes outside of SPI-1 were identified and are
listed in Table 1. Some genes were previously known to affect
T3SS-1 activity, for example, sirA encoding a global response
regulator (11). This provided further evidence that the hemo-
lysis assay was a suitable method for identifying genes and
pathways affecting T3SS-1. Genes not previously known to
affect Salmonella T3SS-1 were involved in a number of differ-
ent biochemical pathways including lipopolysaccharide (LPS)
biosynthesis, fimbriae expression, and DNA repair. Multiple
independent mutations in some systems were identified; for
example, six separate genes in the LPS biosynthetic pathway
were identified, confirming the importance of this pathway in
T3SS-1-mediated hemolysis and markedly reducing the likeli-
hood that the observed phenotypes are due to second-site
defects. Further, the assay reproducibly detected the involve-
ment of specific genes; for example, fadD mutants were iso-
lated five times, and sirA mutants were isolated three times.
The serovar Typhimurium LT2 genome was analyzed to iden-
tify which mutated genes were in operons and therefore po-
tentially sensitive to polar effects. Of those genes identified as
being located in an operon and therefore having potential
polar effects, the majority were in LPS genes. The involvement
TABLE 1. Mutations outside of SPI-1 resulted in impaired T3SS-1-mediated contact-dependent hemolysis by S. enterica serovar Typhimurium
Unique mutant identifier Gene (synonym) Function
Hemolytic activity (% of wild
type SD) in:
STM P22 transductant
M7f4 hns DNA binding protein, global regulator 13.0  4.7b
M17c10 stpA HNS-like global regulator 39.7  26.6
M28f10, M45f10, M49d10c sirA (uvrY) Response regulator controlling virulence gene expression 5.2  6.7 20.02  13.8
M60f1 rfaL LPS core biosynthesis; O-antigen ligase 23.9  4.8b
M7a4 rfaG LPS core biosynthesis; glucosyltransferase I 47.9  5.9b
M37f12 rfaI LPS core biosynthesis; (glucosyl)lipopolysaccharide-
alpha-1,3-D-galactosyltransferase
3.6  5.3b
M5b4 rfbU LPS O-antigen biosynthesis 34.7  6.9
M31f1 rfbI LPS O-antigen biosynthesis 46.9  7.8
M33d10, M38d10 rfbF LPS O-antigen biosynthesis 30.1  16.2b
M31g3 cpsB (rfbM, manC) Mannose-1-phosphate guanyltransferase, involved in
colanic acid biosynthesis
41.4  24.4 48.34  10.7
M14h4 spr (yeiV) Putative lipoprotein, suppresses thermosensitivity of prc
mutants at low osmolarity
56.3  17.6
M16f3 fimW Regulator of type I fimbriae expression 42.9  4.9 25.3  11.5d
M12d5, M14g3, M14h5,
M13e9, M37e9
fadD Long chain fatty acid acyl-CoA synthetase 16.8  22.6 51.9  0.9d
M56c5 ackA Acetate kinase A 48.0  14.1b 27.05  4.3
M49g1 aroD 3-Dehydroquinate dehydratase 45.2  13.9b 61.71  19.8
M54e12 deaD ATP-independent RNA helicase 67.2  22.4b 49.86  15.2
M34c4 uvrB Part of ATP-dependent DNA excision repair enzyme
complex
41.6  20.8
M41a5,c M47a5, M54a5 agaR Transcriptional repressor of aga operon 53.0  14.3 87.47  19.3
M46g10 envC (yibP) Peptidoglycan hydrolase; required for cell division 39.1  6.6
M53h8 yqjB (ecfM) Unknown 55.3  12.8
M44d6, M14h10 yfgA/yfgBa Unknown 69.8  15.5b
M50d1 ycgL/minCa Unknown (ycgL); cell division inhibitor (minC) 61.0  27.1
a Transposon insertion between the two genes.
b Results obtained from additional assay with bacteria corrected to the same OD550.
c STM mutant used for P22 transduction.
d Defined deletion mutant was used rather than a P22 transductant.
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of LPS per se in regulation of T3SS-1 activity should be re-
garded with caution as it is required for membrane integrity
and proper insertion and folding of membrane proteins. In-
deed, some lipid A mutations have already been shown to
impair T3SS-1 function (24).
To confirm that the phenotype of reduced T3SS-1-mediated
hemolysis was due to mutation of the gene identified by trans-
poson insertion sequencing and not to secondary defects, P22
transduction of a subset of the mutants into the archived se-
rovar Typhimurium 4/74 parent strain was performed. Muta-
tion of the desired gene in the resulting transductants was
confirmed by PCR with gene-specific primers. The P22 trans-
ductants were retested three times in the hemolysis assay and
displayed a similar phenotype as the original STM mutant
(Table 1), confirming that the effect on T3SS-1-dependent
hemolysis was most likely due to disruption of the gene iden-
tified by sequencing of the transposon insertion.
For further validation of the screen, fadD was selected as
this gene had previously been identified in a screen of mutants
with reduced expression of the T3SS-1 transcriptional regula-
tor hilA (13). fadD encodes the long-chain fatty acyl-coenzyme
A (CoA) synthetase, which is associated with the inner bacte-
rial membrane and catalyzes the esterification of long-chain
fatty acids into fatty acyl-CoA molecules (reviewed in refer-
ence 4). The fatty acyl-CoA molecules can be incorporated
into phospholipids for membranes or can be further degraded
via the beta-oxidation pathway. A defined fadD deletion mu-
tant was constructed using overlapping PCR followed by allelic
exchange with the pDM4 suicide vector (16). The first 300 and
last 325 nucleotides of fadD were amplified by PCR using the
primer pair FadD_5_xho (5-CTCCTCGAGTTGAAGAAGGT
TTGGCTT-3) and FadD_int2 (5-CAGAATCATATCTTTCT
TAATCATGCCAGCGCGTAAAATACC-3) and the pair
FadD_3_xba (5-CTCTCTAGATCAGGCTTTATTGTCTACT
TT-3) and FadD_int3 (5-TTACGCGCTGGCATGATTAAGA
AAGATATGATTCTGGTTTCT-3; restriction sites are under-
lined). PCR products were used in an overlapping PCR using
FadD_5_xho and FadD_3_xba primers, and the resulting prod-
uct was subcloned into the pCR2.1-TOPO vector (Invitrogen)
and then cloned into pDM4 using XhoI and XbaI restriction sites.
The resulting plasmid pDM4-fadD was introduced into serovar
Typhimurium 4/74 Nalr (17) by conjugation from E. coli
S17.1pir, and merodiploids were selected on LB agar containing
chloramphenicol (25g/ml) and nalidixic acid (20g/ml). Double
recombinants were selected by growing merodiploids to late log
phase in LB medium, plating on LB agar lacking NaCl and con-
taining 6% (wt/vol) sucrose and nalidixic acid, and incubation at
30°C. S. enterica serovar Typhimurium 4/74 Nalr 	fadD300–1360
mutants were verified by colony PCR to lack nucleotides 300 to
1360 of the fadD gene, leaving behind the first 300 and last 325
nucleotides of the gene.
The hemolysis assay was repeated with the defined fadD
mutant, and as with the original STM mutants, the defined
mutant induced less lysis (51.9%  0.9%) of SRBC than sero-
var Typhimurium 4/74 Nalr wild-type (Table 1), further vali-
dating results of the screen of transposon mutants for those
with impaired T3SS-1-dependent hemolytic activity.
Characterization of the effect of fimW mutation on T3SS-1-
dependent hemolysis. Having identified genes which affect the
activity of Salmonella T3SS-1, we sought to characterize one of
these mutants. fimW was selected because this gene had not
previously been linked to type III secretion, but its function is
well characterized. FimW is a negative regulator of type I
fimbriae in serovar Typhimurium (21), which, in turn, contrib-
ute to adherence of bacteria to eukaryotic cells and in some
cases facilitate invasion (3, 5, 7). Type I fimbriae are composed
of FimA subunits which form a fimbrial shaft tipped by the
FimH adhesin, which mediates binding to mannose moieties
on eukaryotic cells (5, 9).
To confirm the effect of mutation of fimW on T3SS-1-medi-
ated contact-dependent hemolysis, a whole-gene deletion mu-
tant was constructed using a similar method as for the fadD
mutant with the primer pair fimW_xho_5 (5-CTCCTCGAGCT
TGCACCTAATCATTTAAC-3) and fimW_mut_3 (5-
CCTTGTAAAAAGTTAAGTGAGTTTACATTGCGCCAGA
AAAGACGATATTC-3) and the pair fimW_xba_3 (5-CTCTC
TAGAGGAAGTTGCGTCAGGACCTC-3) and fimW_mut_5
(5-ATATCGTCTTTTCTGGCGCAATGTAAACTCACT
TAACTTTTTACAAGGC-3; restriction sites are underlined).
The resulting mutant, serovar Typhimurium 4/74 Nalr 	fimW,
contained just the start and stop codons of the fimW gene. For
use as a comparison in some assays a fimA deletion mutant
lacking the fimbrial subunit (serovar Typhimurium 4/74 Nalr
	fimA) was also created using the same method with the
primer pair fimA_xho_5 (5-CTCCTCGAGATGCGACATT
TTATACAAAA-3) and fimA_mut_3 (5-GCCGTTCCCTG
ACGGGATTACATGGATTTCCCTTGAATTACACAC-3)
and the pair fimA_xba_3 (5-CTCTCTAGAACGAAAATGG
AACGCTGACG-3) and fimA_mut_5 (5-TGTAATTCAAG
GGAAATCCATGTAATCCCGTCAGGGAACGGCAGG-3).
The expected phenotypes of the mutants were confirmed by
blotting and mannose-sensitive yeast agglutination. For the dot
blot, bacterial strains were cultured statically in 10 ml of LB
medium containing nalidixic acid (20 g/ml) at 37°C for 48 h.
Whole-cell lysates were prepared by centrifuging 10 ml of
culture, washing the bacterial pellet in PBS, and resuspending
it in 50 l of PBS. The lysates were normalized to equivalent
bacterial numbers, serial dilutions were made, and samples
were heated at 95 to 100°C for 8 min. Four-microliter spots
were applied to Hybond ECL membrane (GE Healthcare) in
two applications of 2 l. The membrane was blocked in 3%
nonfat dried milk in PBS, and immunoblotting was performed
using anti-FimA-glutathione S-transferase antiserum (1:100), a
kind gift from Andreas Ba¨umler, and goat anti-rabbit alkaline
phosphatase-conjugated secondary antibody (1:10,000; Sigma).
Type I fimbriae were detected in the serovar Typhimurium
4/74 Nalr wild-type sample at a dilution of up to 1:200 (Fig. 1).
In contrast, in the serovar Typhimurium 4/74 Nalr 	fimW mu-
tant, type I fimbriae were still detected at the highest dilution
of 1:500, indicating that this strain produces an elevated level
of FimA and, presumably therefore, more type I fimbriae than
the wild-type strain. FimA was not detected in the serovar
Typhimurium 4/74 Nalr 	fimA strain.
As the dot blot assay used whole-cell lysates and could not
distinguish surface-expressed type I fimbriae, a yeast cell slide
agglutination assay was performed based on an adaptation of a
method by Roe et al. (19). Briefly, bacterial strains were cul-
tured overnight statically at 21°C and then diluted 1:2 into 10
ml of fresh LB medium and cultured statically for 90 min at
37°C. These culture conditions mimicked those of the hemo-
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lysis assay, and in addition to providing data on surface expres-
sion levels of type I fimbriae, the assay provided data that could
be correlated to type I fimbrial expression patterns in the
hemolysis assay. Bacteria were pelleted by centrifugation and
resuspended in PBS, with the OD600 of the cultures adjusted to
1.75. Agglutination was assayed on glass slides mixing 15 l of
bacteria with an equal volume of 10 mg/ml Saccharomyces
cerevisiae cell suspension (Sigma). Slides were incubated at 4°C
and monitored periodically for agglutination. Mannose inhibi-
tion of agglutination was confirmed using 3% (wt/vol) D-man-
nose in the yeast suspension. Serovar Typhimurium 4/74 Nalr
	fimW displayed strong yeast cell agglutination within 10 min,
whereas serovar Typhimurium 4/74 Nalr wild-type bacteria dis-
played agglutination only after a 20-min incubation. The sero-
var Typhimurium 4/74 Nalr 	fimA mutant, as expected, did not
agglutinate yeast cells. A negative control of enterohemor-
rhagic E. coli O157:H7 (TUV930), which does not express type
I fimbriae (19), did not cause yeast cell agglutination. Addition
of 3% (wt/vol) D-mannose abolished agglutination in all cases,
indicating that yeast cell agglutination in the serovar Typhi-
murium 4/74 Nalr 	fimW mutant and parent strain was due to
surface expression of type I fimbriae.
In the hemolysis assay the defined fimW mutant induced less
lysis (25.3%  11.5%) of SRBC than serovar Typhimurium
4/74 Nalr wild type (Table 1). Based on these data, we hypoth-
esized that a possible mechanism of action for the role of type
I fimbriae in T3SS-1 activity is a spatial interference effect,
whereby the increased amount of type I fimbriae on the surface
of the fimW mutant prevents the T3SS-1 from efficiently con-
tacting eukaryotic cells. Consistent with this hypothesis, re-
moval of type I fimbriae via mutation of fimA resulted in
increased hemolysis (113.2%  23.0%) compared to the wild-
type strain.
The fadD and fimW mutants behaved differently from wild-
type bacteria in another T3SS-1-dependent assay. A second
read-out of T3SS-1 function, the gentamicin protection assay,
was carried out to measure bacterial invasion of cultured epi-
thelial cells since invasion is a major function of Salmonella
T3SS-1.
Bacterial strains were cultured statically overnight at 25°C in
10 ml of LB medium containing appropriate antibiotics and
then diluted 1:2 in 10 ml of fresh LB medium and cultured
statically for 90 min at 37°C. Confluent monolayers of HeLa
cells in 24-well plates were washed in PBS and incubated for 30
min at 37°C in 5% CO2 in fresh Dulbecco’s modified Eagle’s
medium containing 10% (vol/vol) fetal calf serum. Approxi-
mately 5  105 bacteria were added to each well of HeLa cells
(multiplicity of infection of 2.5), and plates were centrifuged to
facilitate contact of the bacteria with the HeLa cells. Following
a 1-h infection at 37°C in 5% CO2, cells were washed three
times in PBS and fresh Dulbecco’s modified Eagle’s medium
containing 10% fetal calf serum, and 150 g/ml gentamicin was
added. Cells were incubated for 1 h more and then were
washed three times in PBS and lysed by the addition of 100 l
of 1% Triton X-100 in PBS for 5 min. PBS (900 l) was added
to each well, and bacteria were plated onto L-agar plates con-
taining nalidixic acid (20 g/ml) for enumeration of invaded
bacteria. Each bacterial strain was assayed in triplicate in the
invasion assay.
S. enterica serovar Typhimurium 4/74 Nalr 	fadD300–1360
showed an 80% decrease in invasion compared to serovar
Typhimurium 4/74 Nalr wild-type (Fig. 2a), and a control of
serovar Typhimurium 4/74 harboring a transposon insertion in
a gene encoding a structural component of T3SS-1, prgH
(prgH::miniTn5Km2) (17), was unable to invade HeLa cells,
FIG. 1. Analysis of the expression of FimA by serovar Typhimurium
wild-type and fimW-defined deletion mutant. Bacteria were grown stati-
cally at 37°C for 48 h. Whole-cell lysates of the cultures were prepared,
serially diluted, and heated at 95 to 100°C for 8 min. Protein dot blots
were performed using anti-FimA-glutathione S-transferase antiserum, an
alkaline phosphatase-conjugated anti-rabbit secondary antibody, and the
BCIP/NBT (5-bromo-4-chloro-3-indolylphosphate/nitroblue tetrazolium)
detection method. WT, wild type.
FIG. 2. Mutations in type I fimbrial genes affect invasion in cultured epithelial cells. Bacteria were grown statically overnight at 21°C,
subcultured at 1:2, and temperature shifted to 37°C for 90 min to induce expression of T3SS-1. Confluent monolayers of HeLa cells in 24-well plates
were infected with 5  105 CFU/well. At 1 h postinfection cells were washed with PBS, and fresh medium containing 150 g/ml gentamicin was
added for a further hour. Cells were lysed with 1% Triton X-100, and bacteria were enumerated by plating on L-agar. Invasion assays were
performed in the absence (a) and presence (b) of D-mannose. Values represent a typical experiment performed with triplicate samples; error bars
indicate standard error of the mean. WT, wild type.
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indicating that the assay was dependent on a functional
T3SS-1. Under these conditions, serovar Typhimurium 4/74
Nalr 	fimW was more invasive than the wild-type strain (Fig.
2a), contrasting with data from the hemolysis assay. However,
when the invasion assay was repeated in the presence of 0.2 M
D-mannose to block secondary effects of the FimH adhesin,
serovar Typhimurium 4/74 Nalr 	fimW showed a 25% decrease
in invasion compared to the wild-type strain (Fig. 2b). The
FimH adhesin of type I fimbriae binds mannosylated glycopro-
teins on or secreted by eukaryotic cells, facilitating adhesion of
bacteria to eukaryotic cells; this observation suggests that in
the initial invasion assay (Fig. 2a), results were biased by in-
creased type I fimbriae on the fimW mutant strain, thereby
resulting in increased adherence to the HeLa cells. This is
supported by reports that Salmonella type I fimbriae mediate
adhesion in vitro to a variety of cell types (3, 7, 20) and con-
tribute to colonization of pigs in vivo (2).
The differences in the ability of the fadD and fimW mutants
to induce T3SS-1-mediated contact-dependent hemolysis may
be partially due to differences in T3SS-1 secretion. Protein
secretion by Salmonella T3SS-1 can be induced in vitro by a
temperature shift of the bacterial culture from 25°C to 37°C,
resulting in the secretion of large quantities of T3SS-1 effector
proteins into the culture supernatant (26). We used a modifi-
cation of this method to mirror the culture conditions used in
the hemolysis assay. Briefly, bacterial strains were cultured
statically overnight in 10 ml of LB medium at 25°C, diluted 1:2
into 10 ml of fresh LB medium, and cultured statically for 90
min at 37°C. Ten milliliters of culture was pelleted by centrif-
ugation (10,000  g for 10 min) and resuspended in 7.5 ml of
fresh LB medium to remove the background of secreted pro-
teins. Five milliliters was added to 5 ml of PBS and incubated
statically for 4 h at 37°C. At the end of the incubation period,
bacteria were pelleted by centrifugation, and the supernatant
was passed through a 0.45-m-pore-size low-protein-binding
filter. Secreted proteins were collected by incubating the fil-
tered supernatant with 30 l of StrataClean resin (Stratagene).
The resin was washed in PBS and resuspended in sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) loading buffer. Proteins were separated by SDS-PAGE
and stained with Coomassie blue. Western blotting of secreted
proteins was performed using Hybond-ECl membrane, blocked
in 3% (wt/vol) nonfat dried milk and incubated with anti-SipC
(clone F569-cc6c) or anti-SipB (clone F575-AB4) monoclonal
antibodies (generated in-house) at 1g/ml (diluted in 1% [wt/vol]
bovine serum albumin in Tris-buffered saline), followed by don-
key anti-mouse horseradish peroxidase-conjugated secondary an-
tibody (GE Healthcare) at a concentration of 1:10,000. Blots were
developed using chemiluminescence (ECL kit, GE Healthcare).
Secreted protein profiles from both serovar Typhimurium 4/74
Nalr 	fimW and serovar Typhimurium 4/74 Nalr 	fadD300–1360
showed reduced amounts of T3SS-1-secreted proteins (Fig. 3a),
with the fadD mutant showing the least amount of secreted pro-
teins. Western blotting confirmed that both the fadD mutant and
the fimW mutant secreted less SipB and SipC T3SS-1 translocator
proteins than the wild-type strain (Fig. 3b). Samples of the bac-
terial cultures were taken at 0 and 4 h postinoculation for viable
counts. Bacterial numbers were similar for all cultures at each
time point; thus, the mutations did not affect bacterial growth
(data not shown).
Concluding comments. A screen of 5,700 serovar Typhi-
murium 4/74 random transposon mutants identified a number
of novel mutations that have impaired T3SS-1 activity, as
judged by a decrease in T3SS-1-mediated contact-dependent
hemolysis compared to the parent strain. We used a defined
fadD mutant to validate the screen, and our findings from the
hemolysis assay and other T3SS-1-dependent assays correlate
with data by Lucas and colleagues, which identified fadD in a
Tn5 mutagenesis screen for mutants affecting expression of the
T3SS-1 transcriptional activator hilA (14). Interestingly, Lucas
et al. found that fadD affected hilA expression independently of
the fatty acid regulator fadR (13). One possible hypothesis is
that this may represent a novel mechanism that Salmonella has
evolved to utilize the conventional fatty acid pathway to sense
the environment and regulate virulence gene expression ac-
cordingly.
For fimW, which had not previously been implicated in
T3SS-1 activity, we confirmed the impaired T3SS-1 activity
observed in the hemolysis assay using additional T3SS-1-de-
pendent assays. Analysis of T3SS-1-secreted proteins from
both the fadD and fimW mutants revealed that the decreased
T3SS-1 activity correlated with a decrease in the levels of
secreted proteins compared to wild-type bacteria. In particular,
SipB and SipC were reduced in both mutants, and these pro-
teins are required for translocation of other T3SS-1-secreted
proteins into eukaryotic cells and are also responsible for the
T3SS-1-dependent hemolysis by forming a pore in the eryth-
rocyte membrane (15).
The mechanism of action that explains how disrupting a
gene involved in regulation of type I fimbriae expression leads
to a decrease in secretion of T3SS-1 proteins is unclear. We
initially hypothesized that the impaired ability of the fimW
mutant to induce hemolysis was due to a spatial interference
effect, whereby the increased amount of fimbriae on the bac-
terial surface of a fimW mutant prevents T3SS-1 from effi-
ciently contacting and lysing erythrocytes. However, analysis of
T3SS-1-secreted proteins indicated that this is not the sole
explanation as the amounts of T3SS-1-secreted proteins col-
lected from the culture supernatant of the fimW mutant were
less than the amount from the wild-type strain. Thus, there
seems to be a more complex, multifactorial explanation, and at
FIG. 3. The fimW and fadD mutants secrete smaller amounts of
T3SS-1-secreted proteins than wild-type bacteria. Bacteria were grown
statically overnight at 21°C, subcultured 1:2 into 20 ml, and cultured
statically at 37°C for 90 min. Ten milliliters of culture was pelleted by
centrifugation and resuspended in 7.5 ml of fresh LB medium, and 5
ml was added to 5 ml of PBS and incubated statically for 4 h at 37°C.
Secreted proteins were isolated from culture supernatants and sub-
jected to SDS-PAGE followed by Coomassie staining (a) or Western
blotting with anti-SipC and anti-SipB antibodies (b). WT, wild type.
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this stage we are unable to entirely rule out some role for
spatial interference or effects on membrane integrity. Indeed,
it is likely that other genes we identified in the hemolysis screen
that are involved in bacterial surface structures such as LPS
may have a spatial interference explanation for their lack of
hemolysis, either impeding the ability of T3SS-1 to contact
erythrocytes or affecting assembly of T3SS-1 in the bacterial
membrane. The effect of LPS mutations on type III secretion
has been observed in Shigella, where a mutant defective in LPS
O-antigen glucosylation showed reduced epithelial cell inva-
sion in vitro compared to wild-type bacteria (25). This is be-
cause glucosylation of LPS causes a conformational change in
the O antigen, shortening the distance it extends from the
Shigella surface and thereby optimizing access of the T3SS to
the epithelial cells (25). In Yersinia increasing the length of the
adhesin YadA reduced Yop effector translocation via the T3SS
(18), providing further evidence of how bacterial surface struc-
tures impact on T3SS function.
Other genes identified in our screen may have more complex,
and as yet unknown, explanations for their inability to induce
T3SS-1-mediated contact-dependent hemolysis, and characteriz-
ing these mutants could potentially identify new targets for ther-
apeutics.
This work has shown that the Salmonella T3SS-1-dependent
hemolysis assay developed by Miki and colleagues (15) is a
useful method for high-throughput screening of a large num-
ber of mutants for T3SS-1 activity. The method has numerous
advantages including speed, reliability, and sensitivity. It
should be capable of being readily adapted to other bacteria
demonstrating T3SS-dependent hemolytic activity to identify
novel genes and pathways affecting type III secretion in these
organisms.
The authors gratefully acknowledge the financial support of the
Biotechnology and Biological Sciences Research Council, including
grant D010632/1 to E.E.G.
We thank Jo Stevens for helpful discussions and comments on the
manuscript and Eirwen Morgan for technical advice regarding the
STM mutant library.
REFERENCES
1. Abrahams, G. L., and M. Hensel. 2006. Manipulating cellular transport and
immune responses: dynamic interactions between intracellular Salmonella
enterica and its host cells. Cell. Microbiol. 8:728–737.
2. Althouse, C., S. Patterson, P. Fedorka-Cray, and R. E. Isaacson. 2003. Type
I fimbriae of Salmonella enterica serovar Typhimurium bind to enterocytes
and contribute to colonization of swine in vivo. Infect. Immun. 71:6446–6452.
3. Ba¨umler, A. J., R. M. Tsolis, and F. Heffron. 1996. Contribution of fimbrial
operons to attachment to and invasion of epithelial cell lines by Salmonella
typhimurium. Infect. Immun. 64:1862–1865.
4. Black, P. N., and C. C. DiRusso. 2003. Transmembrane movement of exog-
enous long-chain fatty acids: proteins, enzymes and vectorial esterification.
Microbiol. Mol. Biol. Rev. 67:454–472.
5. Boddicker, J. D., N. A. Ledeboer, J. Jagnow, B. D. Jones, and S. Clegg. 2002.
Differential binding to and biofilm formation on, HEp-2 cells by Salmonella
enterica serovar Typhimurium is dependent upon allelic variation in the fimH
gene of the fim gene cluster. Mol. Microbiol. 45:1255–1265.
6. Gala´n, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells
by type III secretion machines. Nature 444:567–573.
7. Guo, A., M. A. Lasaro, J. C. Sirard, J. P. Kraehenbu¨hl, and D. M. Schifferli.
2007. Adhesin-dependent binding and uptake of Salmonella enterica serovar
Typhimurium by dendritic cells. Microbiology 153:1059–1069.
8. Håkansson, S., K. Schesser, C. Persson, E. E. Galyov, R. Rosqvist, F.
Homble´, and H. Wolf-Watz. 1996. The YopB protein of Yersinia pseudotu-
berculosis is essential for the translocation of Yop effector proteins across the
target cell plasma membrane and displays a contact-dependent membrane
disrupting activity. EMBO J. 15:5812–5823.
9. Hancox, L. S., K. S. Yeh, and S. Clegg. 1997. Construction and character-
ization of type 1 non-fimbriate and non-adhesive mutants of Salmonella
typhimurium. FEMS Immunol. Med. Microbiol. 19:289–296.
10. High, N., J. Mounier, M. C. Pre´vost, and P. J. Sansonetti. 1992. IpaB of
Shigella flexneri causes entry into epithelial cells and escape from the phago-
cytic vacuole. EMBO J. 11:1991–1999.
11. Johnston, C., D. A. Pegues, C. J. Hueck, A. Lee, and S. I. Miller. 1996.
Transcriptional activation of Salmonella typhimurium invasion genes by a
member of the phosphorylated response-regulator superfamily. Mol. Micro-
biol. 22:715–727.
12. Kuwae, A., M. Ohishi, M. Watanabe, M. Nagai, and A. Abe. 2003. BopB is
a type III secreted protein in Bordetella bronchiseptica and is required for
cytotoxicity against cultured mammalian cells. Cell. Microbiol. 5:973–983.
13. Lucas, R. L., C. P. Lostroh, C. C. DiRusso, M. P. Spector, B. L. Wanner, and
C. A. Lee. 2000. Multiple factors independently regulate hilA and invasion
gene expression in Salmonella enterica serovar Typhimurium. J. Bacteriol.
182:1872–1882.
14. Ly, K. T., and J. E. Casanova. 2007. Mechanisms of Salmonella entry into
host cells. Cell. Microbiol. 9:2103–2111.
15. Miki, T., N. Okada, Y. Shimada, and H. Danbara. 2004. Characterization of
Salmonella pathogenicity island 1 type III secretion-dependent hemolytic
activity in Salmonella enterica serovar Typhimurium. Microb. Pathog. 37:65–
72.
16. Milton, D. L., R. O’Toole, P. Ho¨rstedt, and H. Wolf-Watz. 1996. Flagellin A
is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 178:1310–
1319.
17. Morgan, E., J. D. Campbell, S. C. Rowe, J. Bispham, M. P. Stevens, A. J.
Bowen, P. A. Barrow, D. J. Maskell, and T. S. Wallis. 2004. Identification of
host-specific colonization factors of Salmonella enterica serovar Typhi-
murium. Mol. Microbiol. 54:994–1010.
18. Mota, L. J., L. Journet, I. Sorg, C. Agrain, and G. R. Cornelis. 2005.
Bacterial injectisomes: needle length does matter. Science 307:1278.
19. Roe, A. J., C. Currie, D. G. Smith, and D. L. Gally. 2001. Analysis of type 1
fimbriae expression in verotoxigenic Escherichia coli: a comparison between
serotypes O157 and O26. Microbiology 147:145–152.
20. Thankavel, K., A. H. Shah, M. S. Cohen, T. Ikeda, R. G. Lorenz, R. Curtiss
III, and S. N. Abraham. 1999. Molecular basis for the enterocyte tropism
exhibited by Salmonella typhimurium type I fimbriae. J. Biol. Chem. 274:
5797–5809.
21. Tinker, J. K., L. S. Hancox, and S. Clegg. 2001. FimW is a negative regulator
affecting type 1 fimbrial expression in Salmonella enterica serovar Typhi-
murium. J. Bacteriol. 183:435–442.
22. Wallis, T. S., and E. E. Galyov. 2000. Molecular basis of Salmonella-induced
enteritis. Mol. Microbiol. 36:997–1005.
23. Warawa, J., B. B. Finlay, and B. Kenny. 1999. Type III secretion-dependent
hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 67:
5538–5540.
24. Watson, P. R., A. Benmore, S. A. Khan, P. W. Jones, D. J. Maskell, and T. S.
Wallis. 2000. Mutation of waaN reduces Salmonella enterica serovar Typhi-
murium-induced enteritis and net secretion of type III secretion system
1-dependent proteins. Infect. Immun. 68:3768–3771.
25. West, N. P., P. Sansonetti, J. Mounier, R. M. Exley, C. Parsot, S. Guadag-
nini, M. C. Pre´vost, A. Prochnicka-Chalufour, M. Delepierre, M. Tanguy,
and C. M. Tang. 2005. Optimization of virulence functions through gluco-
sylation of Shigella LPS. Science 307:1313–1317.
26. Wood, M. W., R. Rosqvist, P. B. Mullan, M. H. Edwards, and E. E. Galyov.
1996. SopE, a secreted protein of Salmonella dublin, is translocated into the
target eukaryotic cell via a sip-dependent mechanism and promotes bacterial
entry. Mol. Microbiol. 22:327–338.
3398 NOTES J. BACTERIOL.
